Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mast Cells and Duodenal Permeability After Acid Perfusion
NCT02664051Phase 4Terminated
- Sponsor
- UZ Leuven
- Start
- Aug 2013
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of sodium cromoglycate in functional dyspepsia (FD) (2 arms), sponsored by UZ Leuven. Primary endpoint: Transepithelial Resistance at 2 weeks. Started Aug 2013; status: terminated.
02
Drugs
sodium cromoglycate
03
Conditions
functional dyspepsia (FD)
Beyond the preview
Go deeper on NCT02664051.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02664051.